Q3 2024 |
45 |
$1.89B |
+$142M |
-$157M |
-$15.2M |
MLTX, PCVX, ACLX, LBPH, EWTX
|
13F-HR |
11/14/2024, 03:11 PM |
Q2 2024 |
47 |
$1.72B |
+$351M |
-$591M |
-$240M |
MLTX, CRBP, ACLX, PCVX, LBPH
|
13F-HR |
8/14/2024, 03:05 PM |
Q1 2024 |
56 |
$2.27B |
+$569M |
-$504M |
+$65.1M |
MLTX, EYPT, ACLX, ALPN, BBIO
|
13F-HR |
5/15/2024, 03:22 PM |
Q4 2023 |
47 |
$2.09B |
+$534M |
-$613M |
-$79.5M |
MLTX, AMAM, EYPT, BBIO, ACLX
|
13F-HR |
2/14/2024, 03:11 PM |
Q3 2023 |
49 |
$1.71B |
+$290M |
-$253M |
+$36.4M |
MLTX, BBIO, AMAM, ACLX, APLS
|
13F-HR |
11/14/2023, 03:25 PM |
Q2 2023 |
61 |
$1.76B |
+$300M |
-$426M |
-$126M |
MLTX, AMAM, APLS, BMEA, BBIO
|
13F-HR |
8/14/2023, 03:19 PM |
Q1 2023 |
72 |
$1.52B |
+$319M |
-$334M |
-$15.4M |
RXDX, MLTX, BMEA, APLS, AMAM
|
13F-HR |
5/15/2023, 03:34 PM |
Q4 2022 |
72 |
$1.49B |
+$181M |
-$213M |
-$32.2M |
RXDX, APLS, ACLX, MLTX, RNA
|
13F-HR |
2/14/2023, 03:17 PM |
Q3 2022 |
72 |
$1.42B |
+$268M |
-$365M |
-$97.6M |
RXDX, APLS, DSGN, ERAS, ACLX
|
13F-HR |
11/14/2022, 03:23 PM |
Q2 2022 |
79 |
$1.29B |
+$253M |
-$183M |
+$69.7M |
TPTX, DSGN, ERAS, RXDX, APLS
|
13F-HR |
8/15/2022, 03:08 PM |
Q1 2022 |
77 |
$1.3B |
+$230M |
-$126M |
+$104M |
TPTX, ERAS, DSGN, RXDX, GRNA
|
13F-HR |
5/16/2022, 03:07 PM |
Q4 2021 |
78 |
$1.68B |
+$152M |
-$344M |
-$192M |
ERAS, TPTX, DSGN, RXDX, FMTX
|
13F-HR |
2/14/2022, 03:19 PM |
Q3 2021 |
88 |
$2.46B |
+$465M |
-$348M |
+$117M |
ERAS, TPTX, AVIR, FMTX, RVMD
|
13F-HR |
11/15/2021, 03:14 PM |
Q2 2021 |
100 |
$2.56B |
+$487M |
-$887M |
-$400M |
TPTX, AVIR, FMTX, BBIO, DSGN
|
13F-HR |
8/16/2021, 03:13 PM |
Q1 2021 |
115 |
$3.47B |
+$728M |
-$419M |
+$309M |
AVIR, TPTX, DSGN, BBIO, FMTX
|
13F-HR |
5/17/2021, 03:46 PM |
Q4 2020 |
99 |
$3.44B |
+$1.01B |
-$450M |
+$562M |
TPTX, AVIR, BBIO, FMTX, OLMA
|
13F-HR |
2/16/2021, 03:21 PM |
Q3 2020 |
87 |
$2.27B |
+$329M |
-$449M |
-$120M |
TPTX, FMTX, RVMD, BBIO, CCXI
|
13F-HR |
11/16/2020, 04:13 PM |
Q2 2020 |
77 |
$2.28B |
+$364M |
-$413M |
-$48.7M |
TPTX, FMTX, CCXI, PRNB, BBIO
|
13F-HR |
8/14/2020, 03:17 PM |
Q1 2020 |
68 |
$1.76B |
+$316M |
-$285M |
+$30.8M |
TPTX, PRNB, BBIO, CCXI, XLRN
|
13F-HR |
5/15/2020, 03:07 PM |
Q4 2019 |
61 |
$2.27B |
+$453M |
-$307M |
+$146M |
TPTX, RETA, MRTX, CCXI, PRNB
|
13F-HR |
2/14/2020, 03:36 PM |
Q3 2019 |
68 |
$1.38B |
+$168M |
-$125M |
+$42.4M |
TPTX, MRTX, APLS, RETA, BBIO
|
13F-HR |
11/14/2019, 03:10 PM |
Q2 2019 |
67 |
$1.58B |
+$459M |
-$244M |
+$215M |
TPTX, MRTX, RETA, APLS, BBIO
|
13F-HR |
8/14/2019, 03:17 PM |
Q1 2019 |
63 |
$1.4B |
+$414M |
-$402M |
+$11.7M |
IFRX, MRTX, ASND, APLS, ANAB
|
13F-HR |
5/15/2019, 03:31 PM |
Q4 2018 |
65 |
$1.1B |
+$159M |
-$163M |
-$3.57M |
MRTX, ANAB, TSRO, APLS, IFRX
|
13F-HR |
2/14/2019, 03:35 PM |
Q3 2018 |
60 |
$1.39B |
+$170M |
-$190M |
-$19.5M |
ANAB, MRTX, NKTR, AVRO, APLS
|
13F-HR |
11/14/2018, 03:15 PM |
Q2 2018 |
56 |
$1.24B |
+$275M |
-$108M |
+$168M |
APLS, MRTX, ANAB, NKTR, IFRX
|
13F-HR |
8/14/2018, 03:11 PM |
Q1 2018 |
49 |
$1.15B |
+$250M |
-$121M |
+$129M |
NKTR, ANAB, APLS, MRTX, IFRX
|
13F-HR |
5/15/2018, 03:54 PM |
Q4 2017 |
49 |
$863M |
+$421M |
-$203M |
+$218M |
ANAB, NKTR, APLS, BPMC, MYOK
|
13F-HR |
2/14/2018, 03:39 PM |
Q3 2017 |
51 |
$566M |
+$111M |
-$217M |
-$107M |
MYOK, RXDX, OMER, ANAB, TBPH
|
13F-HR |
11/14/2017, 03:17 PM |
Q2 2017 |
71 |
$602M |
+$112M |
-$156M |
-$44.1M |
PTLA, TBPH, BLUE, QTNT, OMER
|
13F-HR |
8/14/2017, 03:15 PM |
Q1 2017 |
75 |
$689M |
+$62.4M |
-$154M |
-$91.7M |
TBPH, NVRO, PTI, GLPG, ANAB
|
13F-HR |
5/15/2017, 03:23 PM |
Q4 2016 |
77 |
$742M |
+$99.8M |
-$136M |
-$36.1M |
PTI, TBPH, NVRO, ALDR, EGRX
|
13F-HR |
2/14/2017, 03:22 PM |
Q3 2016 |
84 |
$907M |
+$179M |
-$150M |
+$29.1M |
ALDR, NVRO, TBPH, NERV, PTI
|
13F-HR |
11/14/2016, 02:58 PM |
Q2 2016 |
84 |
$705M |
+$138M |
-$123M |
+$14.7M |
ALDR, NVRO, HRTX, TSRO, NKTR
|
13F-HR |
8/15/2016, 04:12 PM |
Q1 2016 |
84 |
$664M |
+$142M |
-$56M |
+$85.6M |
ALDR, HRTX, SAGE, OMER, NKTR
|
Restatement |
5/17/2016, 04:50 PM |
Q4 2015 |
82 |
$836M |
+$139M |
-$44.1M |
+$94.6M |
ALKS, DYAX, HRTX, EGRX, NBIX
|
13F-HR |
2/16/2016, 04:11 PM |
Q3 2015 |
87 |
$626M |
+$87.6M |
-$53.4M |
+$34.2M |
HRTX, ALKS, NBIX, DYAX, ARDX
|
13F-HR |
11/16/2015, 04:08 PM |
Q2 2015 |
80 |
$752M |
+$157M |
-$169M |
-$12.8M |
ALKS, HRTX, RCPT, ALDR, DYAX
|
13F-HR |
8/14/2015, 04:22 PM |
Q1 2015 |
71 |
$647M |
+$102M |
-$194M |
-$91.2M |
RCPT, ALKS, PBYI, EGRX, BMY
|
13F-HR |
5/15/2015, 04:18 PM |
Q4 2014 |
70 |
$649M |
+$180M |
-$134M |
+$46.7M |
RCPT, PBYI, CELG, OVAS, ALKS
|
13F-HR |
2/17/2015, 04:20 PM |
Q3 2014 |
65 |
$486M |
+$178M |
-$73.5M |
+$104M |
PBYI, RCPT, JAZZ, DYAX, KERX
|
13F-HR |
11/14/2014, 11:21 AM |
Q2 2014 |
54 |
$377M |
+$139M |
-$181M |
-$41.8M |
RCPT, OMER, QCOR, KPTI, DYAX
|
13F-HR |
8/14/2014, 11:21 AM |
Q1 2014 |
46 |
$435M |
+$202M |
-$126M |
+$75.8M |
MDVN, CBST, PBYI, BMRN, RCPT
|
13F-HR |
5/15/2014, 11:20 AM |
Q4 2013 |
37 |
$345M |
$0 |
$0 |
|
MDVN, CBST, KERX, DYAX, PBYI
|
13F-HR |
2/14/2014, 10:50 AM |